Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
RET oncogene in MEN2, MEN2B, MTC and other forms of thyroid cancer Lodish MB; Stratakis CAExpert Rev Anticancer Ther 2008[Apr]; 8 (4): 625-32Hereditary medullary thyroid carcinoma (MTC) is caused by specific autosomal dominant gain-of-function mutations in the RET proto-oncogene. Genotype-phenotype correlations exist that help predict the presence of other associated endocrine neoplasms as well as the timing of thyroid cancer development. MTC represents a promising model for targeted cancer therapy, as the oncogenic event responsible for initiating malignancy has been well characterized. The RET proto-oncogene has become the target for molecularly designed drug therapy. Tyrosine kinase inhibitors targeting activated RET are currently in clinical trials for the treatment of patients with MTC. This review will provide a brief overview of MTC and the associated RET oncogenic mutations, and will summarize the therapies designed to strategically interfere with the pathologic activation of the RET oncogene.|Carcinoma, Medullary/*genetics/mortality/therapy[MESH]|Genotype[MESH]|Humans[MESH]|Multiple Endocrine Neoplasia Type 2a/*genetics/mortality/therapy[MESH]|Multiple Endocrine Neoplasia Type 2b/*genetics/mortality/therapy[MESH]|Mutation[MESH]|Phenotype[MESH]|Proto-Oncogene Mas[MESH]|Proto-Oncogene Proteins c-ret/antagonists & inhibitors/*genetics/metabolism[MESH]|Receptor Protein-Tyrosine Kinases/antagonists & inhibitors/genetics[MESH]|Survival Rate[MESH]|Thyroid Neoplasms/*genetics/mortality/therapy[MESH]|Thyroidectomy[MESH] |
